Literature DB >> 30368751

From Cancer Immunoediting to New Strategies in Cancer Immunotherapy: The Roles of Immune Cells and Mechanics in Oncology.

Virginia Aragon-Sanabria1, Gloria B Kim1, Cheng Dong2.   

Abstract

For the last three decades, the concept of immunoediting has evolved to characterize our increasing understanding of the interactions between cells from the immune system and cancer development. Elucidating the role of immune cells in the progression of cancer has been very challenging due to their dual role; the immune system can either suppress tumor formation by killing cancer cells, or it can also promote tumor growth. Revealing how immune cells are hampered by the tumor microenvironment and how they aid tumor progression has signaled strategies to reverse these effects and control cancer cell growth; this has been the advent of immunotherapy design. More recently, the role of physical forces in the process of immunoediting has been highlighted by multiple studies focusing on understanding how force changes in the stiffness of the extracellular matrix and fluid flow shear stress contribute to tumor development. Using models in vitro that incorporate biomechanical components, it has been shown that these physical aspects are not only important during the formation and growth of primary tumors, but in the metastatic process as well. In this way, we have also gained insight into the interactions occurring within the vascular system, which are highly affected by the dynamics of physical collisions between cells and by shear forces. Here, we review the concept of cancer immunoediting with an emphasis on biomechanics and conclude with a summary on current immunotherapies and potential new strategies.

Entities:  

Keywords:  Cancer immunoediting; Cell biomechanics; Cell signaling; Cell-mediated drug delivery; Drug delivery; Tumor microenvironment

Mesh:

Year:  2018        PMID: 30368751     DOI: 10.1007/978-3-319-95294-9_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Overexpression of pressure-responsive miRNA-5703 inhibits pressure-induced growth and metastasis of liver cancer.

Authors:  Si Shen; Wenli Zhou; Ji Xuan; Weijun Xu; Huabing Xu; Miaofang Yang; Liang Zhu; Zhuoxin Yang; Benzhao Yang; Bin Shi; Ying Zhao; Fangyu Wang
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

2.  BCL11B regulates MICA/B-mediated immune response by acting as a competitive endogenous RNA.

Authors:  Mengyao Qian; Jingwen Geng; Kaili Luo; Zheng Huang; Qinkai Zhang; Jian-An Zhang; Liying Ji; Jianmin Wu
Journal:  Oncogene       Date:  2019-10-31       Impact factor: 8.756

3.  Effects of propofol and sevoflurane on tumor killing activity of peripheral blood natural killer cells in patients with gastric cancer.

Authors:  Lili Ai; Hao Wang
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

Review 4.  Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges.

Authors:  Kei Kunimasa; Taichiro Goto
Journal:  Int J Mol Sci       Date:  2020-01-17       Impact factor: 5.923

5.  TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation.

Authors:  Kui Zang; Liangliang Hui; Min Wang; Ying Huang; Xingxing Zhu; Bin Yao
Journal:  Front Oncol       Date:  2021-02-22       Impact factor: 6.244

6.  Blood Immunosenescence Signatures Reflecting Age, Frailty and Tumor Immune Infiltrate in Patients with Early Luminal Breast Cancer.

Authors:  Lieze Berben; Asier Antoranz; Cindy Kenis; Ann Smeets; Hanne Vos; Patrick Neven; Giuseppe Floris; Hans Wildiers; Sigrid Hatse
Journal:  Cancers (Basel)       Date:  2021-05-02       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.